SCHEMBL25069185

SCHEMBL25069185

SN1CCN(C(c2ccc(Cl)cc2)c2ccc(Cl)cc2)CC1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP2D6 P10635 3/20 0.61
▸ CYP19A1 P11511 1/20 0.61
▸ SMN1; SMN2 Q16637 2/20 0.61
▸ CHRM2 P08172 2/20 0.61
▸ HTR1A P08908 2/20 0.61
▸ ADRA2A P08913 2/20 0.61
▸ CHRM1 P11229 2/20 0.61
▸ DRD1 P21728 2/20 0.61
▸ TBXA2R P21731 2/20 0.61
▸ SLC6A2 P23975 2/20 0.61
▸ SLC6A4 P31645 2/20 0.61
▸ ADRA1A P35348 2/20 0.61
▸ DRD3 P35462 2/20 0.61
▸ SLC6A3 Q01959 2/20 0.61
▸ KCNH2 Q12809 2/20 0.61
▸ OPRM1 P35372 2/20 0.61
▸ ALDH1A1 P00352 1/20 0.61
▸ USP2 O75604 1/20 0.61
▸ CYP3A4 P08684 1/20 0.61
▸ KDM4E B2RXH2 2/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16757326 0.83 CYP2D6 (0.66) CYP2D6CYP19A1SMN1; SMN2CHRM2HTR1A
SCHEMBL7668121 0.82 CHRM2 (0.83) CYP2D6CYP19A1SMN1; SMN2CHRM2HTR1A
SCHEMBL2056217 0.80 CHRM2 (0.86) CYP2D6CYP19A1SMN1; SMN2CHRM2HTR1A
SCHEMBL25068897 0.80 CHRM2 (0.64) CYP2D6CYP19A1SMN1; SMN2CHRM2HTR1A
SCHEMBL13309489 0.77 CYP2D6 (0.71) CYP2D6CYP19A1SMN1; SMN2CHRM2HTR1A
SCHEMBL3263282 0.77 GPX4 (0.58) CYP2D6CYP19A1SMN1; SMN2CHRM2HTR1A
SCHEMBL13309488 0.77 CYP2D6 (0.71) CYP2D6CYP19A1SMN1; SMN2CHRM2HTR1A
SCHEMBL6824843 0.77 CYP2D6 (0.71) CYP2D6CYP19A1SMN1; SMN2CHRM2HTR1A
Homochlorcyclizine SCHEMBL30402 0.77 DRD3 (1.00) CYP2D6SMN1; SMN2CHRM2HTR1AADRA2A
SCHEMBL1137956 0.76 CYP2D6 (1.00) CYP2D6CYP19A1SMN1; SMN2CHRM2HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230055961-A1 PENTAFLUOROBENZENESULFONAMIDE DERIVATIVES AND USES THEREOF DUNAD THERAPEUTICS LTD. (GB) 2023-02-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230055961-A1 PENTAFLUOROBENZENESULFONAMIDE DERIVATIVES AND USES THEREOF FURIN, PFAS, CFTR CYP2D6 129/4885CYP19A1 1200/4885SMN1; SMN2 566/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback